USPTO serial 77670839
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary F. Love
MARY F. LOVE LAW OFFICE OF MARY F. LOVE3509 CONNECTICUT AVE NW PMB 130WASHINGTON, DC 20008-2400UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, oral contraceptives | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 11, 2009 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Sep 11, 2009 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Sep 11, 2009 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Aug 9, 2009 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| May 22, 2009 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Apr 28, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 20, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 20, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 19, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 17, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 18, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 18, 2009 | NWAP | NEW APPLICATION ENTERED | — |